Wednesday - August 19, 2026
FDA Center for Drug Evaluation & Research Issues Warning Letter to Auriga Research
August 19, 2026
WASHINGTON, Aug. 19 -- The U.S. Department of Health and Human Services Food and Drug Administration issued the following warning letter to Auriga Research Pvt. Ltd. from its Center for Drug Evaluation and Research:

* * *

Recipient: Dr. Saurabh Arora, Managing Director and CEO, Auriga Research Pvt. Ltd., 3/17 Kirti Nagar, Industrial Area, New Delhi 110015, India, (b)(4)

Issuing Office: Center for Drug Evaluation and Research (CDER), United States

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products